Clinical trials: Healthy Control Group
Focal Dystonia
EEG and EMG Studies of Hand Dystonia
This study will examine how the brain operates during execution and control of voluntary movement and what goes wrong with these processes in disease.
- Trial name
- NCT00025701
- Where
- United States
- Volunteers
- 75 people, healthy volunteers welcome
- Sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
Healthy, Postprandial
Acute Effects of Wine Consumption on Healthy Volunteers
The purpose of this study is to investigate whether red and white wine consumption has acute effects on postprandial biochemical markers related to platelet aggregation, inflammation and oxidative stress compared to water or…
- Trial name
- winepost (NCT01627912)
- Testing
- Robola, Cabernet Sauvignon wines
- Where
- Greece
- Volunteers
- 10 people, healthy volunteers welcome
- Sponsor
- Harokopio University
Healthy
Single Rising Dose Study to Assess Safety, Tolerability and Pharmacokinetics of BI 661051.
The objective of the current study is to investigate safety, tolerability, and pharmacokinetics of treatment with BI 661051 rising single doses administered as oral drinking solution (powder in bottle) in healthy male subjects.
- Trial name
- NCT01343719
- Testing
- BI 661051
- Where
- Germany
- Volunteers
- 64 people, healthy volunteers welcome
- Sponsor
- Boehringer Ingelheim
Healthy
A Study to Test How Different Doses of BI 765423 Are Taken up in the Body of Healthy Men
The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics (PK) of BI 765423 in healthy male subjects following intravenous administration of single rising doses.
- Trial name
- NCT05658107
- Testing
- BI 765423
- Where
- Belgium
- Volunteers
- 64 people, healthy volunteers welcome
- Sponsor
- Boehringer Ingelheim
Energy Expenditure, Metabolic Health
Effects of NMES on Energy Expenditure, Glycaemia and Hormonal Responses to Glucose Ingestion
The purpose of this study is to investigate whether self-selected neuromuscular stimulation (NMES) affects energy expenditure, glycaemia and hormonal responses in healthy men and women
- Trial name
- NCT04389736
- Testing
- Sitting, Standing, Self-selected maximal intensity of neuromuscular electrical stimulation
- Where
- Taiwan
- Volunteers
- 9 people, healthy volunteers welcome
- Sponsor
- National Taiwan Normal University
Renal Anemia
Pharmacokinetics Comparison Study of JT1801 and NESP® After Single Dose Administration in Chinese Health Male Volunteers
The purpose of this study is to compare the similarity of major pharmacokinetic parameters after a single intravenous administration of JT1801 and NESP® in chinese healthy male volunteers.
- Trial name
- NCT05864261
- Testing
- JT1801 60ug, NESP 60ug
- Where
- China
- Volunteers
- 74 people, healthy volunteers welcome
- Sponsor
- Yi Fang
Healthy
Safety and Pharmacokinetics of BIRB 796 BS Tablets Administered to Healthy Human Subjects
Study to assess the safety and pharmacokinetics of BIRB 796 BS tablets administered as multiple daily doses at various dose levels.
- Trial name
- NCT02209805
- Testing
- BIRB 796 BS, low dose, BIRB 796 BS, high dose
- Volunteers
- 49 people, healthy volunteers welcome
- Sponsor
- Boehringer Ingelheim
Rabies Virus Infection
Safety, Pharmacokinetics, and Pharmacodynamic Testing of Rabies mAb CBB 1
rabies mab CBB 1 is mainly used for passive immunization of patients bitten or scratched by rabies or other animals carrying rabies virus, this study mainly studies the safety, tolerability, pharmacokinetics, neutralizing…
- Trial name
- NCT05832073
- Testing
- Natural full human monoclonal antibody CBB 1 injection, Rabies Human Immunoglobulin (HRIG), Lyophilized rabies vaccine for human use (Vero cells)
- Where
- China
- Volunteers
- 152 people, healthy volunteers welcome
- Sponsor
- Changchun BCHT Biotechnology Co.
Healthy
Acute Effects of Breakfast Compared With No Breakfast on Cognitive Function and Subjective State in 11-13 Year Old Children
This study is a school-based, randomised, controlled, parallel groups trial to examine the acute effect of breakfast (ready-to-eat-cereal and milk) vs.
- Trial name
- NCT03979027
- Testing
- Breakfast: ready-to-eat-cereal and milk
- Where
- United Kingdom
- Volunteers
- 234 people, healthy volunteers welcome
- Sponsor
- University of Leeds
Healthy Adults
The Feasibility of TECH: Tablet Enhancement of Cognition and Health for Healthy Adults
This study assess the feasibility of novel cognitive intervention utilizing tablet apps (TECH protocol: Tablet Enhancement of Cognition and Health) in terms of relevance, adherence, suitable challenges, training time etc.
- Trial name
- NCT02955303
- Testing
- TECH: Tablet Enhancement of Cognition and Health
- Where
- Israel
- Volunteers
- 10 people, healthy volunteers welcome
- Sponsor
- Assuta Hospital Systems
Pain-related Fear, Kinesiophobia (Fear of Movement)
Pain-Related Fear and Motor Control in Healthy Volunteers
The goal of this clinical trial is to learn how experimentally induced movement-related threat affects emotional, autonomic, and motor responses in healthy adults.
- Conditions
- Pain-related Fear, Kinesiophobia (Fear of Movement), Movement-Related Threat
- Trial name
- Domokiss (NCT07636603)
- Testing
- Movement-Related Threat Induction, Neutral Movement Condition
- Where
- France
- Volunteers
- 26 people, healthy volunteers welcome
- Sponsor
- Universite de Picardie Jules Verne
Healthy Japanese
A Verification Study to Evaluate the Safety of Long-term Consumption of the Test Food
This clinical study aims to verify the safety of consumption of plasmalogen-containing food for 12 weeks in healthy Japanese. The study will also exploratory assess blood plasmalogen levels and the effects of…
- Trial name
- NCT06715475
- Testing
- Food containing plasmalogen, Food not containing plasmalogen
- Where
- 2 sites in Japan
- Volunteers
- 24 people, healthy volunteers welcome
- Sponsor
- Orthomedico Inc.
Healthy Population
Evaluation of the Tolerance of Three Masks Under Dermatological Control.
This is a monocentric, open and randomized study. The purpose is to evaluate the cutaneous tolerance of three medical masks (class I medical device) after 3 consecutive days of use on a population with normal or sensitive skin.
- Trial name
- NCT05193799
- Testing
- Investigational devices must be used 8 hours per day
- Where
- France
- Volunteers
- 98 people, healthy volunteers welcome
- Sponsor
- Groupe Kolmi Hopen
Parkinson's Disease, Progressive Supranuclear Palsy(PSP)
Study on Artificial Intelligence-Based Facial and Speech-Related Patterns in Parkinson's Disease and Their Digital Biomarkers
This research employs AI to analyze facial expressions and speech patterns, aiming to develop new digital tools for diagnosing and differentiating Parkinson's disease and similar disorders.
- Conditions
- Parkinson's Disease, Progressive Supranuclear Palsy(PSP), Multiple System Atrophy, Healthy Control
- Trial name
- NCT07392411
- Testing
- video recording
- Where
- China
- Volunteers
- 720 people, healthy volunteers welcome
- Sponsor
- Beijing Tiantan Hospital
Malaria, Falciparum, Malaria
Sporozoite Challenge of Polyprotein Vaccinees
This study examines the ability of two new malaria vaccines (FP9-PP and MVA-PP) to prevent the development of malaria infection after controlled exposure to the parasite.
- Trial name
- NCT00375128
- Testing
- FP9-PP (FP9 polyprotein), MVA-PP (Modified Virus Ankara polyprotein)
- Where
- 2 sites in United Kingdom
- Volunteers
- 26 people, healthy volunteers welcome
- Sponsor
- European Vaccine Initiative
Coronavirus Infections, Healthy
Phase II/III Randomized Clinical Trial of Booster Dose of COVID-19 (Recombinant, Inactivated) Vaccine
NDV-HXP-S is an inactivated COVID-19 vectored-vaccine virus using the Newcastle Disease Virus as basis and expressing Spike (S) protein from SARS-CoV-2 stabilized in pre-fusion form with Hexapro technology.
- Trial name
- Butanvac (NCT05354024)
- Testing
- NDV-HXP-S 10μg, BNT162b2 30μg
- Where
- 6 sites in Brazil
- Volunteers
- 4,400 people, healthy volunteers welcome
- Sponsor
- Butantan Institute
Healthy Subjects
A Study to Investigate the Safety, Tolerability, PK, and PD of CKD-508 in Healthy Participants
This Phase 1, randomized, parallel-group, placebo-controlled, double-blinded study aims to evaluate the safety, PK, and PD of CKD-508 when administered multiple times once daily to healthy participants.
- Trial name
- NCT06727396
- Testing
- CKD-508 Tablet
- Where
- United States
- Volunteers
- 44 people, healthy volunteers welcome
- Sponsor
- Chong Kun Dang Pharmaceutical
Rheumatoid Arthritis, Healthy Control
Adipokines as Predictors of Foot Function, Pain, and Disability in Patients With Rheumatoid Arthritis
Significant increase in the levels of serum adiponectin, ADA, and hsCRP was reported in all RA patients compared to controls. Compared to patients with early RA, the increase in these markers significantly correlated with disease…
- Trial name
- NCT04036669
- Volunteers
- 160 people, healthy volunteers welcome
- Sponsor
- King Saud University
Pharmacokinetics of Alefacept
A Study of Pharmacokinetics and Safety of Alefacept in Caucasian and Japanese Healthy Volunteers
The objective of this study is to compare the pharmacokinetic and pharmacodynamic properties and safety profile of alefacept in Caucasian and Japanese healthy subjects
- Trial name
- NCT00653822
- Testing
- alefacept
- Where
- United States
- Volunteers
- 75 people, healthy volunteers welcome
- Sponsor
- Astellas Pharma Inc
Motivation, Memory
MRI Neurofeedback and Brain Circuits Related to Motivation in Healthy Participants
The purpose of this research study is to understand how healthy individuals self-regulate motivation by observing brain activity using magnetic resonance imaging (MRI).
- Conditions
- Motivation, Memory, Self-regulation
- Trial name
- NCT05929898
- Testing
- Ventral tegmental area of dopaminergic midbrain (VTA) fMRI neurofeedback
- Where
- United States
- Volunteers
- 190 people, healthy volunteers welcome
- Sponsor
- Duke University
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.